“…These compounds were identified in mammalian tissue and fluid samples (Peura et al, 1980;Airaksinen and Kari, 1981a;Melchior and Collins, 1982;Beck and Faull, 1986;Collins, 1988;Tsuchiya et al, 1994aTsuchiya et al, , 1994bHaber et al, 1996;Musshoff and Daldrup, 1998) and found to possess various neuropharmacological properties (Deitrich and Erwin, 1980;Buckholtz, 1980;Airaksinen and Kari, 1981b;Melchior and Collins, 1982;Nagatsu, 1997;Storch et al, 2002). The reactions of AA with indoleamines and dopamine have been extensively documented (Whaley and Govindachari, 1951;MacIsaac, 1961;Cohen and Collins, 1970;Herraiz and Ough, 1993;Callaway et al, 1994Callaway et al, , 1996Cox and Cook, 1995;Foppoli et al, 2002). Several reports suggested that the presence of MTBCs and SAL in mammalian tissue and fluid samples was caused by the reaction of AA with indoleamines and dopamine in vivo (MacIsaac, 1961;Cohen and Collins, 1970;Yamanaka et al, 1970;Collins et al, 1979;Callaway et al, 1996;Musshoff et al, 2000;Foppoli et al, 2002;Jamal et al, 2003) since the condensation reactions readily occur under physiological conditions (Whaley and Govindachari, 1951;MacIsaac, 1961;Cohen and Collins, 1970;Callaway et al, 1994Callaway et al, , 1996…”